![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Single Doses of Long-Acting Capsid Inhibitor GS-6207 Administered by Subcutaneous Injection Are Safe and Efficacious in People Living With HIV
|
|
|
17th EACS 2019 Nov 8 Basel
Reported by Jules Levin
Eric S. Daar,1 Cheryl McDonald,2 Gordon Crofoot,3 Peter Ruane,4 Gary Sinclair,5 Heena Patel,6 Rebecca Begley,6 Ya-Pei Liu,6 Diana M. Brainard,6 Robert H. Hyland,6 Martin S. Rhee6
1The Lundquist Institute, Torrance, California, USA; 2Tarrant County Infectious Disease Associates, Fort Worth, Texas, USA; 3Gordon E. Crofoot MD, PA, Houston, Texas; 4Ruane Clinical Research Group, Inc., Los Angeles, California; 5Prism Health North Texas, Dallas, Texas; 6Gilead Sciences, Inc., Foster City, California
![1112191](../images/111219/111219-6/1112191.gif)
![1112192](../images/111219/111219-6/1112192.gif)
![1112193](../images/111219/111219-6/1112193.gif)
![1112194](../images/111219/111219-6/1112194.gif)
![1112195](../images/111219/111219-6/1112195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|